Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SRY-box transcription factor 21 antisense divergent transcript 1: Regulatory roles and clinical significance in neoplastic conditions and Alzheimer's Disease. | J Cancer | 2023 | 37928430 | PubTator, text mining | PubMed |
| P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions. | Oncol Rep | 2023 | 37921068 | PubTator, text mining | PubMed |
| FTO facilitates cancer metastasis by modifying the m6A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer. | Cell Commun Signal | 2023 | 37919739 | PubTator, text mining | PubMed |
| Circulating levels of miR125a, miR126, and miR146a-5p in patients with obstructive sleep apnea and their relation with markers of endothelial dysfunction. | PLoS One | 2023 | 37917636 | PubTator, text mining | PubMed |
| Advances in understanding effects of miRNAs on apoptosis, autophagy, and pyroptosis in knee osteoarthritis. | Mol Genet Genomics | 2023 | 37914978 | PubTator, text mining | PubMed |
| Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus. | Lupus | 2023 | 37906972 | PubTator, text mining | PubMed |
| Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges. | Genes (Basel) | 2023 | 37895255 | PubTator, text mining | PubMed |
| Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review. | Genes (Basel) | 2023 | 37895198 | PubTator, text mining | PubMed |
| MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets. | Cancers (Basel) | 2023 | 37894390 | PubTator, text mining | PubMed |
| PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics. | Cancers (Basel) | 2023 | 37894321 | PubTator, text mining | PubMed |
| In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer. | Biomedicines | 2023 | 37893081 | PubTator, text mining | PubMed |
| The relationship between prognosis of patients with traumatic brain injury and microRNA biogenesis proteins. | Ulus Travma Acil Cerrahi Derg | 2023 | 37889026 | PubTator, text mining | PubMed |
| Reappraisal of the Concept of Accelerated Aging in Neurodegeneration and Beyond. | Cells | 2023 | 37887295 | PubTator, text mining | PubMed |
| Arsenic in Drinking Water and Diabetes. | Water (Basel) | 2023 | 37886432 | PubTator, text mining | PubMed |
| Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma. | J Oral Maxillofac Pathol | 2023 | 37854932 | PubTator, text mining | PubMed |
| Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer. | J Immunother Cancer | 2023 | 37852737 | PubTator, text mining | PubMed |
| miR-6076 targets BCL6 in SH-SY5Y cells to regulate amyloid-β-induced neuronal damage. | J Cell Mol Med | 2023 | 37849385 | PubTator, text mining | PubMed |
| The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens. | Technol Cancer Res Treat | 2023 | 37849311 | PubTator, text mining | PubMed |
| Circular RNAs in vascular diseases. | Front Cardiovasc Med | 2023 | 37840954 | PubTator, text mining | PubMed |
| The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases. | Ageing Res Rev | 2023 | 37832609 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=11